Chiara Cremolini
0000-0002-0520-4841
Publication & Citation Trends
Publications
0 total
HER-2 gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM study
Cited by 0
Semantic Scholar
Effectiveness of FTD/TPI plus bevacizumab and impact of prior bevacizumab exposure in patients with mCRC: the Italian FLOWER study
Cited by 0
Semantic Scholar
730MO Trifluridine/tipiracil in combination with capecitabine and bevacizumab as upfront treatment for metastatic colorectal cancer: first results of the phase II TriComB study by GONO
Cited by 0
Semantic Scholar
LBA32 Panitumumab retreatment followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA (ctDNA): Final results of the randomized PARERE trial by GONO
Cited by 0
Semantic Scholar
Abstract 6372: Combined tissue and liquid biopsy improves outcomes in advanced solid tumors: an exploratory analysis of the ROME trial
Cited by 1
Semantic Scholar
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial
Cited by 15
Semantic Scholar
139P ROME Trial: Predictive value of TMB cutoffs, concordance, and treatment line in immunotherapy for hTMB/MSS cancers
Cited by 0
Semantic Scholar
15P The ROME trial: Personalized target therapy and immunotherapy in the breast cancer subgroup
Cited by 1
Semantic Scholar
Research Topics
Colorectal Cancer Treatments and Studies
(738)
Genetic factors in colorectal cancer
(249)
Gastric Cancer Management and Outcomes
(215)
Lung Cancer Treatments and Mutations
(182)
Cancer Genomics and Diagnostics
(172)
Affiliations
Université Claude Bernard Lyon 1
University of Pisa
University of Southern California
Royal Marsden NHS Foundation Trust
Memorial Sloan Kettering Cancer Center